Literature DB >> 2046133

Long-term survival of patients with AIDS, Pneumocystis carinii pneumonia, and respiratory failure.

Y Friedman1, C Franklin, S Freels, M H Weil.   

Abstract

OBJECTIVE: --To evaluate the long-term survival of patients admitted to the medical intensive care unit, Cook County Hospital, Chicago, Ill, with Pneumocystis carinii pneumonia and acute respiratory failure.
DESIGN: --Cohort study over a 4-year period.
SETTING: --Municipal teaching hospital. PATIENTS: --Seventy-three consecutive patients who had 75 episodes of P carinii pneumonia and acute respiratory failure were followed up from the time of hospital admission until their deaths or the termination of the study. OUTCOME MEASURES: --Duration of survival from the time of initial hospital admission with diagnoses of P carinii pneumonia and acute respiratory failure.
RESULTS: --Consistent with recent reports of improved short-term outcome, the immediate hospital survival was 47% (35/75). The 1-year survival was 37% (95% confidence interval, 26% to 49%). Two patients have survived for 40 months. Almost three quarters of the patients who survived hospitalization lived for at least 1 year.
CONCLUSIONS: --The long-term prognosis for patients with the acquired immunodeficiency syndrome, P carinii pneumonia, and acute respiratory failure is now substantially better than anticipated. Respiratory failure due to P carinii pneumonia does not necessarily signify the terminal phase of human immunodeficiency virus infection. Accordingly, patients with the acquired immunodeficiency syndrome, P carinii pneumonia, and acute respiratory failure can be appropriate candidates for life support in medical intensive care units.

Entities:  

Mesh:

Year:  1991        PMID: 2046133

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  6 in total

1.  Continuous positive airway pressure by face mask or mechanical ventilation in patients with human immunodeficiency virus infection and severe Pneumocystis carinii pneumonia.

Authors:  B Gachot; B Clair; M Wolff; B Régnier; F Vachon
Journal:  Intensive Care Med       Date:  1992       Impact factor: 17.440

2.  Behavioral medicine interventions can improve the quality-of-life and health of persons with HIV disease.

Authors:  K J Sikkema; J A Kelly
Journal:  Ann Behav Med       Date:  1996-03

3.  Gamma interferon stimulates rat alveolar macrophages to kill Pneumocystis carinii by L-arginine- and tumor necrosis factor-dependent mechanisms.

Authors:  J F Downing; D L Kachel; R Pasula; W J Martin
Journal:  Infect Immun       Date:  1999-03       Impact factor: 3.441

4.  The effects of immune status and race on health service use among people with HIV disease.

Authors:  J D Piette; V Mor; K Mayer; S Zierler; T Wachtel
Journal:  Am J Public Health       Date:  1993-04       Impact factor: 9.308

5.  The effect of human immunodeficiency virus infection on the distribution and outcome of pneumonia in intensive care units.

Authors:  K J Tucker; B Anton; H J Tucker
Journal:  West J Med       Date:  1992-12

6.  Survival with AIDS in Massachusetts, 1979 to 1989.

Authors:  G R Seage; S Oddleifson; E Carr; B Shea; L Makarewicz-Robert; M van Beuzekom; A De Maria
Journal:  Am J Public Health       Date:  1993-01       Impact factor: 9.308

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.